9G8/SRp20 Antibodies

Santa Cruz Biotechnology features a diverse variety of 9G8/SRp20 monoclonal antibodies for research focused on understanding splicing factors. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 9G8/SRp20 plays a vital role in regulating pre-mRNA splicing, which directly impacts gene expression and cellular function. Alternative splicing processes influenced by 9G8/SRp20 are fundamental in development and disease progression. Research has shown that 9G8/SRp20 activity is essential for maintaining normal cellular operations and preventing splicing-related disorders. Scientists studying 9G8/SRp20 can uncover new insights about gene regulation mechanisms and their connection to various diseases. Understanding 9G8/SRp20 function continues to reveal important aspects of molecular pathways and potential therapeutic targets. Investigating 9G8/SRp20 with Santa Cruz Biotechnology monoclonal antibodies enables researchers to advance scientific knowledge and contribute to therapeutic breakthroughs.